Birdie Biopharmaceuticals, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Birdie Biopharmaceuticals, Inc..The latest application filed is for "anti-pd-l1 combinations for treating tumors".

Company Profile

25.26.32

Birdie Biopharmaceuticals, Inc. - Grand Cayman KY
Birdie Biopharmaceuticals, Inc. - Camana Bay KY
Birdie Biopharmaceuticals, Inc. - Camana Bay, Grand Cayman KY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-pd-l1 Combinations For Treating Tumors App 20220251212 - Li; Lixin	2022-08-11
Anti-cd20 Combinations For Treating Tumors App 20220204641 - Li; Lixin	2022-06-30
Immune Modulatory Compositions And Methods For Treating Cancers App 20220175762 - Li; Lixin	2022-06-09
Anti-egfr Combinations For Treating Tumors App 20220089749 - Li; Lixin	2022-03-24
Anti-PD-L1 combinations for treating tumors Grant 11,279,761 - Li March 22, 2	2022-03-22
Anti PD-L1 Conjugates for Treating Tumors App 20220033503 - Li; Lixin ; et al.	2022-02-03
Immune Modulatory Combinations And Methods For Treating Cancers App 20220016152 - Li; Lixin ; et al.	2022-01-20
Anti-CD20 combinations for treating tumors Grant 11,220,552 - Li January 11, 2	2022-01-11
Anti-her2 Combinations For Treating Tumors App 20210363271 - Li; Lixin	2021-11-25
Anti-her2 Combinations For Treating Tumors App 20210347911 - Li; Lixin	2021-11-11
Pharmaceutical Compositions App 20210330664 - Li; Lixin	2021-10-28
Anti-EGFR combinations for treating tumors Grant 11,136,397 - Li October 5, 2	2021-10-05
Anti PD-L1 conjugates for treating tumors Grant 11,130,812 - Li , et al. September 28, 2	2021-09-28
2-amino-quinoline Derivatives App 20210261548 - LI; Lixin ; et al.	2021-08-26
2-amino-quinoline Derivatives App 20210261549 - LI; Lixin ; et al.	2021-08-26
Imidazoquinoline Compounds And Uses Thereof App 20210214354 - Yang; Lihu	2021-07-15
2-amino-quinoline derivatives Grant 11,053,240 - Li , et al. July 6, 2	2021-07-06
Anti-HER2 combinations for treating tumors Grant 11,046,781 - Li June 29, 2	2021-06-29
Compounds And Compositions For Immunotherapy App 20200353093 - Li; Lixin	2020-11-12
Compounds And Compositions For Immunotherapy App 20200345860 - Li; Lixin	2020-11-05
Compounds and compositions for immunotherapy Grant 10,780,180 - Li Sept	2020-09-22
Compounds And Compositions For Treating Her2 Positive Tumors App 20200276327 - Li; Lixin	2020-09-03
Compounds and compositions for immunotherapy Grant 10,744,206 - Li A	2020-08-18
Compounds For Targeted Immunotherapy App 20200246478 - Kind Code	2020-08-06
Compounds For Targeted Immunotherapy App 20200179527 - Li; Lixin	2020-06-11
Compounds for targeted immunotherapy Grant 10,660,971 - Li	2020-05-26
2-amino-quinoline Derivatives App 20200055851 - LI; Lixin ; et al.	2020-02-20
Compounds for targeted immunotherapy Grant 10,548,988 - Li Fe	2020-02-04
Compounds and compositions for treating EGFR expressing tumors Grant 10,548,985 - Li Fe	2020-02-04
Compounds And Compositions For Immunotherapy App 20190269789 - Li; Lixin	2019-09-05
Compounds And Compositions For Immunotherapy App 20190269790 - Li; Lixin	2019-09-05
Compounds and compositions for immunotherapy Grant 10,328,158 - Li	2019-06-25
Combination Therapy Compositions And Methods For Treating Cancers App 20190099415 - Li; Lixin	2019-04-04
Anti-pd-l1 Combinations For Treating Tumors App 20190048084 - Li; Lixin	2019-02-14
Anti-cd20 Combinations For Treating Tumors App 20190016819 - Li; Lixin	2019-01-17
Anti-egfr Combinations For Treating Tumors App 20190016808 - Li; Lixin	2019-01-17
Anti-her2 Combinations For Treating Tumors App 20190002583 - Li; Lixin	2019-01-03
Anti-pd-l1 Combinations For Treating Tumors App 20180346572 - Li; Lixin	2018-12-06
Compounds For Targeted Immunotherapy App 20180177887 - Li; Lixin	2018-06-28
Compounds For Targeted Immunotherapy App 20180177888 - Li; Lixin	2018-06-28
Compounds and Compositions for Immunotherapy App 20180110874 - Li; Lixin	2018-04-26
Compounds for targeted immunotherapy Grant 9,878,052 - Li January 30, 2	2018-01-30
Compounds and compositions for immunotherapy Grant 9,827,329 - Li November 28, 2	2017-11-28
Anti PD-L1 Conjugates for Treating Tumors App 20170290923 - Li; Lixin ; et al.	2017-10-12
Anti-pd-l1 Combinations For Treating Tumors App 20170114137 - Li; Lixin	2017-04-27
Combination Therapy Compositions And Methods For Treating Cancers App 20170056391 - Li; Lixin	2017-03-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.